Physician profile
Christopher Haley
NPI 1013368851
$5,027.05
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,001 · 2020: $184 · 2021: $278 · 2022: $541 · 2024: $24.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $24.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $24.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $2,163.02 | 2019-2021 | |
| Novartis Pharma Ag | $1,012.93 | 2019 | |
| Abbvie INC. | $602.33 | 2019-2022 | |
| Janssen Scientific Affairs, LLC | $253.29 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $217.25 | 2019 | |
| Galderma Laboratories, L.P. | $196.20 | 2020-2022 | |
| Genzyme Corporation | $143.90 | 2019-2022 | |
| Janssen Biotech, INC. | $131.60 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $116.00 | 2022 | |
| Ucb, INC. | $93.86 | 2022-2024 | Bimzelx |
| Almirall LLC | $58.43 | 2019 | |
| Leo Pharma INC. | $38.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Haley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.